However, efforts aimed at stimulating such approaches to develop a vaccine against HIV-1 have been so far unsuccessful, possibly because most vaccine prototypes were aimed at rapidly activating CD4+ T-cells after HIV-1 infection. Here, CD4 is linked to HIV-1 infection.